Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Male Subject”

Showing 15 of 0 results

Early research (Phase 1)Study completedNCT02183298
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 1356 BS in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 36
Early research (Phase 1)Study completedNCT03464227
What this trial is testing

Test the Safety, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous Doses of UCB0107 in Healthy Male Subjects

Who this might be right for
Healthy Male Volunteers
UCB Biopharma S.P.R.L. 52
Early research (Phase 1)Ended earlyNCT01416870
What this trial is testing

Bioequivalence of Bicalutamide New Formulation in Japan

Who this might be right for
Healthy
AstraZeneca 102
Early research (Phase 1)Study completedNCT02173665
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 1356 BS Administered to Healthy Male Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 64
Early research (Phase 1)Study completedNCT01093742
What this trial is testing

HM10560A in Healthy Male Subject

Who this might be right for
Healthy
Hanmi Pharmaceutical Company Limited 32
Early research (Phase 1)Study completedNCT01161355
What this trial is testing

Phase I, Exploratory, Single Centre, Single Oral Dose AZD9668 and Intravenous Microdose of [C14] AZD9668, Healthy Subject

Who this might be right for
Healthy
AstraZeneca 6
Early research (Phase 1)Study completedNCT01611805
What this trial is testing

Japanese Phase I of GSK1605786

Who this might be right for
Crohn's Disease
GlaxoSmithKline 30
Early research (Phase 1)Study completedNCT04312568
What this trial is testing

Evaluate Safety, Tolerability and Pharmacokinetics of Fadanafil （XZP-5849）in Chinese Healthy Adult Male Subjects

Who this might be right for
Healthy Subject
Sihuan Pharmaceutical Holdings Group Ltd. 66
Not applicableStudy completedNCT05011799
What this trial is testing

The Peer Genetic Study

Who this might be right for
Healthy SubjectProstate Carcinoma
Thomas Jefferson University 149
Early research (Phase 1)Study completedNCT02182323
What this trial is testing

Safety, Tolerance, and Pharmacokinetics of Single Oral Doses of BI 201335 NA and Bioavailability in Healthy Male Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 74
Early research (Phase 1)Study completedNCT02529293
What this trial is testing

A Clinical Trial Investigating the Intra-subject Variability of Pharmacokinetics and Glucodynamics of BioChaperone Insulin Lispro U-100 Product and U-200 Product in Healthy Volunteers

Who this might be right for
Healthy
Adocia 26
Early research (Phase 1)Study completedNCT02052713
What this trial is testing

Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State

Who this might be right for
Urologic Diseases
GlaxoSmithKline 78
Early research (Phase 1)Study completedNCT03214874
What this trial is testing

Within Subject Variability Study of ER Torsemide 20 mg Tablet in Healthy Subjects

Who this might be right for
Congestive Heart FailureChronic Kidney Diseases
Sarfez Pharmaceuticals, Inc. 24
Early research (Phase 1)Study completedNCT01093729
What this trial is testing

HM11260C in Healthy Male Subject

Who this might be right for
Healthy
Hanmi Pharmaceutical Company Limited 41
Early research (Phase 1)Study completedNCT05666687
What this trial is testing

An Open-label, Adaptive Design, Positron Emission Tomography Study in Healthy Male Participants to Characterize Receptor Occupancy by MIJ821 in the Brain

Who this might be right for
Major Depressive Disorder
Novartis Pharmaceuticals 10

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation